Carretero, Julian <br/><br/>
Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors.  [electronic resource] 

 -  Cancer cell  Jun 2010 
 - 547-59 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccr.2010.04.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AMP-Activated Protein Kinase Kinases<br/>AMP-Activated Protein Kinases<br/>Animals<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Cell Adhesion--genetics<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Cell Transdifferentiation--genetics<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--therapeutic use<br/>Female<br/>Focal Adhesion Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Focal Adhesions--genetics<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic--genetics<br/>Genomics<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Lung Neoplasms--drug therapy<br/>MAP Kinase Kinase 1--antagonists & inhibitors<br/>MAP Kinase Kinase 2--antagonists & inhibitors<br/>Mice<br/>Mice, Mutant Strains<br/>Mice, Nude<br/>Neoplasm Metastasis--drug therapy<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Phosphorylation--genetics<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proteomics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>RNA Interference<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases<br/>Up-Regulation--genetics<br/>Xenograft Model Antitumor Assays<br/>ras Proteins--genetics<br/>src-Family Kinases--antagonists & inhibitors